Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-26-004259

Options or other derivatives

  • Director acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bradsher Neal C · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-01 Grant or award : show line 1 in the form OPTION TO PURCHASE COMMON SHARES +125,000 125,000 D
Loading xslF345X06/ownership.xml…